BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 5368085)

  • 21. [Coagulation and fibrinolysis following hemolytic transfusion shock].
    Dosne AM
    Ann Med Interne (Paris); 1971 Nov; 122(11):1123-8. PubMed ID: 5150313
    [No Abstract]   [Full Text] [Related]  

  • 22. Exploration of intraglomerular phenomena by measurement of the level of fibrin degradation products in the renal vein blood.
    Conte J; Boneu B; Mignon-Conte ; Suc JM
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):915-26. PubMed ID: 4807811
    [No Abstract]   [Full Text] [Related]  

  • 23. Fibrin deposition in the ribbit kidney produced by protease inhibitors.
    Beller FK; Mitchell PS; Gorstein F
    Thromb Diath Haemorrh; 1967 May; 17(3-4):427-39. PubMed ID: 5301528
    [No Abstract]   [Full Text] [Related]  

  • 24. [Injections of tissue extracts and autologous hemolysates in the dog. Effects on the factors of hemostasis].
    Dosne AM; Josso F; Soulier JP; Lavergne JM; Malmejac J
    Nouv Rev Fr Hematol; 1968; 8(1):21-34. PubMed ID: 4232147
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.
    Lovely RS; Boshkov LK; Marzec UM; Hanson SR; Farrell DH
    Br J Haematol; 2007 Nov; 139(3):494-503. PubMed ID: 17910639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
    Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
    Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of sodium and calcium on the conversion of fibrinogen to fibrin].
    Marguerie G; Hudry G; Hollard D
    Thromb Diath Haemorrh; 1970 Dec; 24(3):373-84. PubMed ID: 5503938
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors.
    Taketomi T; Szlam F; Vinten-Johansen J; Levy JH; Tanaka KA
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):761-7. PubMed ID: 17982317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of reptilase on respiratory insufficiency induced by intravenous infusion of thrombin and AMCA (tranexamic acid) in the dog.
    Busch C; Lindquist O; Saldeen T
    Bibl Anat; 1973; 12():254-9. PubMed ID: 4790359
    [No Abstract]   [Full Text] [Related]  

  • 30. Factor XIII consumption as an indicator of thrombin generation.
    Triantaphyllopoulos DC
    J Lab Clin Med; 1974 Jul; 84(1):74-80. PubMed ID: 4833844
    [No Abstract]   [Full Text] [Related]  

  • 31. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
    Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
    J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
    Dempfle CE
    Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin interactions with fibrinogen and fibrin.
    Mosesson MW
    Semin Thromb Hemost; 1993; 19(4):361-7. PubMed ID: 8140428
    [No Abstract]   [Full Text] [Related]  

  • 34. Conjunctive administration of intravenous heparin attenuates cross-linked fibrin degradation in patients treated with streptokinase.
    Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR
    Thromb Haemost; 1996 Sep; 76(3):339-43. PubMed ID: 8883267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of factor XII (Hagemann's) in activation of the blood anticoagulation system].
    Kudriashov BA; Kalishevskaia TM; Baskova IP; Strukova SM; Kovaleva TN
    Vopr Med Khim; 1969; 15(5):486-94. PubMed ID: 5368086
    [No Abstract]   [Full Text] [Related]  

  • 36. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of mammal submandibular gland glycoderivatives on human hemostatic system.
    Menghi G; Lai G; Piciotti D; Ravaglia F
    Cell Mol Biol; 1989; 35(3):263-70. PubMed ID: 2776172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A functional assay of fibrinoformation in the newborn (author's transl)].
    Merino J; GarcĂ­a-Conde J; Benet I
    Sangre (Barc); 1977; 22(4):439-52. PubMed ID: 897954
    [No Abstract]   [Full Text] [Related]  

  • 39. Sulfated sericin is a novel anticoagulant influencing the blood coagulation cascade.
    Sano M; Tamada Y; Niwa K; Morita T; Yoshino G
    J Biomater Sci Polym Ed; 2009; 20(5-6):773-83. PubMed ID: 19323889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of topical fibrin glue, fibrinogen, and thrombin in preventing seroma formation in a rat model.
    Lindsey WH; Becker DG; Hoare JR; Cantrell RW; Morgan RF
    Laryngoscope; 1995 Mar; 105(3 Pt 1):241-3. PubMed ID: 7877410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.